For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Emerson Electric Co. (EMR) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Low · Gem Score -19 (−100…+100 Quality+Value blend) · Quality 43 · Value -69 · Sentiment -18 (timing only, not weighted) · Composite fair value $69.54 vs $158.71 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Emerson Electric Co.
EMR NYSEEmerson Electric Co. is a global technology and software company specializing in industrial automation solutions. Headquartered in St. Louis, Missouri, Emerson focuses on helping industrial, commercial, and infrastructure customers optimize operations, enhance safety, and improve energy efficiency. The company operates through segments such as Final Control, Measurement and Analytical, Discrete Automation, Safety and Productivity, Intelligent Devices, and Software and Control, providing a broad portfolio of hardware and software products. These offerings include valves, sensors, gauges, switches, and advanced automation platforms that support process control, monitoring, and data-driven decision-making across industries such as energy, chemicals, life sciences, manufacturing, and utilities. Emerson Electric Co. plays a significant role in the automation and digitalization of industrial environments, delivering integrated solutions that connect field devices, control systems, and enterprise software to improve reliability, quality, and operational performance for its customers worldwide.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 4.04
Total Equity: $20.30B
Shares: 566,700,000
Total Debt: $13.12B
Cash: $1.54B
EBITDA: $5.16B
Total Debt: $13.12B
Cash: $1.54B
Revenue: $18.02B
Revenue: $18.02B
Revenue: $18.02B
Total Equity: $20.30B
Tax Rate: 23.7%
Equity: $20.30B
Total Debt: $13.12B
Cash: $1.54B
Current Liabilities: $9.80B
Long-Term Debt: $8.32B
Total Debt: $13.12B
Total Equity: $20.30B
Shares: 566,700,000
Shares: 566,700,000
CapEx: -$431.00M
Shares: 566,700,000
Stock Price: $158.71
Net Income: $2.29B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 7, 2026 4:43am (16d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $18.2B | $19.6B | $15.2B | $17.5B | $18.0B |
| Cost of Revenue | $10.7B | $11.4B | $7.7B | $8.6B | $8.5B |
| Gross Profit | $7.6B | $8.2B | $7.4B | $8.9B | $9.5B |
| Operating Expenses | $4.7B | $4.8B | $4.7B | $5.9B | $5.9B |
| Operating Income | $2.9B | $3.4B | $2.7B | $3.0B | $3.6B |
| Net Income | $2.3B | $3.2B | $13.2B | $2.0B | $2.3B |
| EBITDA | $3.9B | $4.5B | $3.8B | $4.7B | $5.2B |
| EPS | $3.85 | $5.44 | $23.00 | $3.44 | $4.06 |
| EPS (Diluted) | $3.82 | $5.41 | $22.88 | $3.43 | $4.04 |
Balance Sheet (Annual)
Last updated: Aug 7, 2026 12:05am (16d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2.4B | $1.8B | $8.1B | $3.6B | $1.5B |
| Total Current Assets | $8.4B | $8.5B | $13.8B | $10.2B | $8.6B |
| Total Assets | $24.7B | $35.7B | $42.7B | $44.2B | $42.0B |
| Current Liabilities | $6.2B | $7.8B | $5.0B | $5.7B | $9.8B |
| Long-Term Debt | $5.8B | $8.3B | $7.6B | $7.2B | $8.3B |
| Total Liabilities | $14.8B | $19.4B | $16.1B | $16.7B | $21.7B |
| Total Equity | $9.9B | $16.3B | $26.6B | $27.5B | $20.3B |
| Retained Earnings | $26.0B | $28.1B | $40.1B | $40.8B | $40.6B |
Cash Flow (Annual)
Last updated: Aug 7, 2026 4:43am (16d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.6B | $2.9B | $637.0M | $3.3B | $3.1B |
| Capital Expenditure | -$581.0M | -$531.0M | -$363.0M | -$419.0M | -$431.0M |
| Free Cash Flow | $3.0B | $2.4B | $274.0M | $2.9B | $2.7B |
| Acquisitions (net) | -$1.6B | -$5.7B | -$705.0M | -$8.3B | -$37.0M |
| Net Debt Issued / (Repaid) | -$308.0M | $2.5B | -$741.0M | -$547.0M | $1.0B |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$500.0M | -$500.0M | -$2.0B | -$435.0M | -$1.2B |
| Net Change in Cash | -$961.0M | -$550.0M | $6.2B | -$4.5B | -$2.0B |
Growth Trends (YoY %)
Last updated: Aug 7, 2026 4:43am (16d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +7.6% | -22.7% | +15.3% | +3.0% |
| Gross Profit Growth | +8.3% | -9.3% | +19.6% | +7.1% |
| Operating Income Growth | +17.8% | -20.4% | +9.0% | +23.1% |
| Net Income Growth | +40.3% | +309.1% | -85.1% | +16.5% |
| EBITDA Growth | +15.1% | -15.4% | +23.4% | +11.0% |
Dividend History (Last 20)
Last updated: Aug 7, 2026 12:05am (16d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-15 | $0.56 | — | — | — |
| 2026-02-13 | $0.56 | — | — | — |
| 2025-11-14 | $0.56 | — | — | — |
| 2025-08-15 | $0.53 | — | — | — |
| 2025-05-16 | $0.53 | — | — | — |
| 2025-02-14 | $0.53 | — | — | — |
| 2024-11-15 | $0.53 | — | — | — |
| 2024-08-16 | $0.53 | — | — | — |
| 2024-05-16 | $0.53 | — | — | — |
| 2024-02-15 | $0.53 | — | — | — |
| 2023-11-16 | $0.53 | — | — | — |
| 2023-08-10 | $0.52 | — | — | — |
| 2023-05-11 | $0.52 | — | — | — |
| 2023-02-16 | $0.52 | — | — | — |
| 2022-11-09 | $0.52 | — | — | — |
| 2022-08-11 | $0.52 | — | — | — |
| 2022-05-12 | $0.52 | — | — | — |
| 2022-02-10 | $0.52 | — | — | — |
| 2021-11-10 | $0.52 | — | — | — |
| 2021-08-12 | $0.51 | — | — | — |
Deep Analysis
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-19 08:50Even the bull case prices 67% below today — the ratio here measures the model-vs-market gap, not payoff odds. Another quarter like the worst recent one costs 76%.
| Case | Growth | Margin | Fair value | vs price ($158.71) |
|---|---|---|---|---|
| Bull — recovery | +10% | 15.9% | $52.64 | -67% |
| Base — stabilizes | +6% | 13.8% | $42.19 | -73% |
| Bear — keeps slipping | +3% | 11.8% | $33.25 | -79% |
| Stress — last quarter repeats | +3% | 13.8% | $37.80 | -76% |
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-11Emerson's monetized unit is physical content and plant-capacity-linked software, not human seats, so AI-driven labor reduction inside customer plants does not shrink Emerson's revenue while it does cut Emerson's own project engineering, commissioning and configuration hours - a rare case where automation deflates the cost side without deflating the price side.
The high-margin layer - advanced process control, simulation, optimization - is exactly where ML surrogate models trained on plant historian data can approximate decades of physics-based IP, letting a hyperscaler or AI-native vendor sit above the DCS and relegate Emerson to certified hardware and wiring.
Whether Emerson owns the AI reasoning layer on top of its own control data or gets reduced to a data source for someone else's plant copilot. Observable: AspenTech renewal pricing and attach rates, and whether new plant projects specify Emerson optimization or a third-party AI layer over DeltaV.
IEC 61508 functional-safety certification, decades of installed final-control and measurement base with switching costs measured in turnaround windows, the global field service network, and validated process models tied to specific plant assets.
AI Lens thesis
AI reaches Emerson through three distinct channels that must not be blended: first, demand - AI datacenter, power generation, LNG and semiconductor fab construction directly increases the measurement, final control and discrete automation content Emerson sells, a straightforward volume tailwind unrelated to Emerson's own AI capability; second, cost - a large share of Emerson's delivery is engineering hours for configuration, commissioning and application support, and generative tooling compresses that cost while customers keep paying for the outcome, which is visible in the gross margin move from 41.5 percent to 52.8 percent and operating margin to 20.2 percent even though mix explains much of it; third, and the only genuinely dangerous channel, substitution at the software layer - Emerson bought AspenTech precisely to escape hardware multiples, and AspenTech's value rests on proprietary physics-based process models that data-driven AI can partially approximate from telemetry the customer already owns, so the software transition thesis and the AI risk are the same variable. The physical and liability core is close to untouchable; nobody runs a refinery emergency shutdown on an unvalidated model and no operator wants to own that liability. The question is whether Emerson captures the intelligence layer above its own iron or merely hosts it.
What the market may be underestimating
Upside AspenTech-style pricing is generally tied to plant capacity, asset count or throughput rather than user seats, so the seat-compression mechanism that threatens most enterprise software simply does not apply here - AI making plant engineers ten times more productive leaves Emerson's billing unit intact.
Downside A meaningful slice of Emerson's services and project revenue is priced off engineering effort; if AI deflates the hours faster than automation content grows, customers will demand the savings back at bid time, and the recent share-loss gap of about 5 points versus industry growth suggests limited pricing power to resist that.
Outcome range spread 40
Claude Reading
Looking at the raw quarterly cadence first: revenue has climbed from $4.18B (Dec-24) to $4.87B (Jun-26), roughly 16% over six quarters, with net margins stabilizing in the 13-15% band after the anomalous 21.6% Sep-24 print (which likely contains a divestiture gain — the Sep-23 NI of $13.22B on the annual line confirms Emerson has been booking large one-time items from the Climate Technologies sale and AspenTech restructuring). Stripping those, the underlying business is doing ~$18B revenue, ~$2.3B normalized NI, ~$2.67B FCF. At $88.5B market cap plus ~$11.6B net debt, EV is ~$100B — so 5.6x EV/sales and 37x FCF for a business compounding revenue at 3-9% depending on which window you pick. That is a genuinely stretched multiple for an industrial, full stop.
The synthesis verdict of $61-65 fair value strikes me as too punitive, however. A DCF that spits out $65 on a company generating $2.67B FCF implies you're capitalizing FCF at roughly 14x — that's a distressed-industrial multiple, not appropriate for an installed-base process automation franchise with 53% gross margins and AspenTech's genuinely recurring software revenue mixed in. Even Roper-lite skepticism should land you at 22-25x FCF, or roughly $85-95/share. So I partially agree with the "overvalued" direction but dissent from the magnitude. The pre-flight is closer to right: the 39x P/E prices in 8-10% growth and margin expansion, and the trailing numbers show 3% recent revenue YoY — that gap is the actual problem, not a mythical $65 floor.
The contrarian case worth taking seriously: operating margin has moved from ~15% in FY22 to 20.2% in FY25, and if AspenTech consolidation continues to shift mix toward software (higher gross margins, recurring), the "Roper-lite" narrative isn't purely fictional. FCF CAGR of 212% is noise from a low base but FCF conversion is now healthy. The current ratio of 0.88 and $13B debt against $1.5B cash is worth flagging — the synthesis' "high debt risk" alarm is overstated for a company throwing off $3.1B OCF, but it does constrain buyback capacity and makes the equity more sensitive to rate cycles. Insider activity is uniformly one-sided sells (11,500 shares in June, multiple February sales), zero opens — that's consistent with a fully-valued-to-overvalued read from the people who know most. Not a scream, but noteworthy.
Where the models are weakest: the narrative layer correctly identifies that ~$60-70 of the price is story, but the "160% premium to DCF" framing is only true if you accept a punitive DCF. I'd frame it as 40-50% premium to a defensible fair value of ~$105-115, which reflects normalized FCF at 22x plus modest software optionality. The momentum module's -58.4% earnings CAGR is a garbage number driven by the FY23 $13.22B NI blip — analysts and models keying off it are misreading the trajectory. Recent earnings YoY of +16.5% is the real signal, and it's decent but not 39x-worthy. Macro headwinds flag matters: process automation demand is tied to energy capex and industrial capacity utilization, both softening into 2026. Net: overvalued, but the entry point I'd want is $105-115, not $61. At $158 you're paying full retail for a transformation that's real but partial, in a cyclical wrapper, with insiders quietly distributing.
GPT Reading
At $158.71, Emerson is being valued like a high-quality compounder in the middle of a successful mix shift, but the reported numbers still look much more like a good industrial business than a software-like one. Revenue has improved from $17.49B in FY24 to $18.02B in FY25, and the last four quarters annualize to roughly $18.6B, so the top line is growing, but only modestly: the most recent quarter was $4.87B versus $4.55B a year earlier, about 7% growth, while the trailing “recent revenue yoy” signal is only 3%. Net income is also improving in a cleaner way than the headline P/E suggests: quarterly earnings have stepped up from $485M, $586M, $637M, $605M, $618M to $718M over the last six quarters, and the latest quarter’s 14.7% net margin is the best in that run outside the anomalous 21.6% quarter in 2024. That is a solid operating story. The problem is valuation: against FY25 net income of $2.29B, an $88.5B market cap is nearly 39x earnings; against $2.67B of free cash flow, it is about 33x FCF; and on enterprise value, 19.4x EBITDA and 5.6x revenue are rich for a business with single-digit organic-looking growth and ROIC of 8.7%.
The raw financial profile does not support that kind of multiple expansion yet. Gross margin is strong at 52.8%, and operating margin at 20.2% is healthy, but those are good industrial numbers, not obviously transformational numbers. Return on equity is only 11.3%, return on assets 5.5%, and the balance sheet is fine but not pristine: $13.12B of debt against $1.54B of cash leaves meaningful net leverage, while a current ratio below 0.88 is another reminder this is not an asset-light software model. Cash conversion also deserves skepticism. Operating cash flow of $3.10B versus net income of $2.29B is respectable, but not exceptional enough to excuse a premium multiple, and the “FCF CAGR” statistic is flattered by a low base rather than a clear structural jump in earnings power. The huge 2023 annual net income of $13.22B is obviously non-comparable, which also means anyone leaning on multi-year earnings trend data without adjustment can get misled. Strip out the noise and Emerson looks like a capable, improving, mature industrial franchise priced for a much faster and more durable growth algorithm than the reported numbers currently show.
What stands out most is that the market appears to be capitalizing the possibility of a better business mix before it is clearly visible in returns. If Emerson were already demonstrating sustained double-digit revenue growth, recurring revenue dominance, or a path to 25%+ operating margins with materially higher ROIC, a premium could make sense. But the actual progression is much less dramatic: FY25 revenue grew only about 3% year over year, while net margin moved from 11.3% in FY24 to 12.7% in FY25. Nice, yes; valuation-justifying, no. Even the quarterly cadence suggests steady execution rather than step-function change. Paying nearly 5x sales and 39x earnings for steady execution in an industrial end-market facing macro headwinds is a bad setup unless the next leg of growth is much stronger than the last one. My read is simple: this is a high-quality business, but the stock price already discounts the successful completion of the transformation.
The best case against that view is that the market is intentionally looking through today’s accounting and valuing Emerson on forward mix, not trailing multiples. A smart bull would point to the consistency in quarterly revenue, the upward earnings trend from $485M to $718M in five quarters, and the recovery in margins from 10.9% to the mid-teens as evidence that integration and portfolio repositioning are working. They would also argue that a 52.8% gross margin industrial company is already not a plain-vanilla machinery name, and that if software/content rises inside the portfolio, today’s 20.2% operating margin and 8.7% ROIC understate normalized economics. On that view, 2025 is a bridge year and investors are paying up for 2027-2028 earnings power. I take that seriously. But even then, the burden of proof is high: a company on roughly $18-19B of revenue does not usually earn a near-$90B equity value unless growth and conversion are visibly inflecting. Right now, the numbers show improvement, not escape velocity.
What would change my mind is not another quarter of “better than feared” execution; it is evidence that the premium is earning itself. Specifically, I would want to see revenue growth sustain above 8-10% for several quarters, annual free cash flow move convincingly above $3.5B, and operating margin expand beyond 22% without financial engineering or one-offs. I would also want to see ROIC move out of the high-single digits and into the low teens, because that would indicate the portfolio really is becoming structurally better. If those things happen, a price in the $150s becomes much easier to defend. Without them, fair value is materially lower; I would be more comfortable in a $105-$125 range, where the stock would still command a premium for quality without assuming the transformation is already complete.
Grok Reading
The numbers describe a solid but ordinary industrial franchise being asked to carry a software multiple it has not earned. Emerson put up $18.02B of revenue and $2.29B of net income in fiscal 2025, with operating margin at 20.2% and free cash flow of $2.67B — respectable cash conversion on a ~$431M capex base. Sequential quarters show modest progress: the June 2026 print of $4.87B revenue and a 14.7% net margin is the best recent combination, and trailing net margins have climbed from the low teens. That is real operational improvement after the portfolio reshaping. What it is not is growth that supports a 39x P/E, 19.4x EV/EBITDA, or 5.6x EV/sales. Recent revenue growth is only ~3% year-over-year; the 9% revenue CAGR is backward-looking and inflated by mix shifts and acquisitions. ROIC sits at 8.7% and ROE at 11.3% — mid-single to low-double digit returns on capital that look pedestrian next to a market cap of $88.5B. FCF yield is roughly 3%. Net debt is material ($13.1B debt against $1.5B cash), the current ratio is 0.88, and the balance sheet is not fortress-like. The valuation synthesis fair value near $61–65 is directionally correct: the market is paying roughly 2.5x a sober DCF of the hardware-and-controls cash flows that still dominate the P&L.
The prior models’ “mature earner” label fits; the platform-monopoly narrative does not. AspenTech and the software-enabled automation story are real strategic moves, and gross margin of 53% shows the mix is not pure capital equipment. But software has not yet rewritten the growth or return profile enough to justify pricing Emerson like a compounding industrial software compounder. Earnings CAGR is deeply negative on a multi-year basis because of one-time gains and portfolio exits (the $13.2B NI year in 2023 is noise); strip that away and you have a mid-teens margin industrial growing low-to-mid single digits with a 1.4% dividend yield. Insider activity is a string of sales and gifts with no open-market accumulation. Secondary signals flag weak cash-flow quality, macro headwinds, and below-sector benchmarks. The stock is priced for 8–10% organic growth plus steady margin expansion that the recent run-rate does not deliver.
The strongest case against this read is that the transformation is earlier than the numbers show and the multiple compression thesis is fighting a durable industrial-IoT and energy-transition bid. Believers will point to the sequential margin grind (net margin from 10.9% in March 2025 to 14.7% most recently), the AspenTech integration still ramping recurring software, and the fact that operating income rose from $2.96B to $3.65B year-over-year even on only 3% sales growth — operating leverage is visible. They will argue EV/EBITDA of 19x is not absurd versus automation peers if software mix and aftermarket stickiness keep expanding, and that FCF of $2.67B gives management firepower to buy back stock or bolt on more high-margin software. A smart opponent also notes that the 2023 NI spike and the revenue step-down from the old $19.6B base reflect deliberate portfolio simplification, so trailing multiples and CAGRs understate the quality of the remaining franchise. I weigh that evidence as real but insufficient: the improvement is incremental, not transformative, and at $158.71 the stock already capitalizes a best-case software outcome. Moderate narrative durability means any miss on software growth or a cyclical industrial slowdown resets the multiple quickly; you are not paid to wait for proof at 39x earnings and a 3% FCF yield.
I would flip toward neutral or constructive only on sustained evidence that software and recurring revenue are driving mid-teens organic growth with ROIC pushing through the mid-teens, or on a material drawdown that brings the stock toward high-teens free-cash-flow yields and mid-20s earnings multiples while margins hold. Near-term, watch the next two quarters for revenue growth re-accelerating above 6–7% with net margins holding above 14%, plus any update that software mix and AspenTech synergies are large enough to move group ROIC by 200+ bps. Absent that, the premium is a narrative tax.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Emerson has meaningfully upgraded its business mix since 2021: gross margin has climbed from 41.5% to 52.8% and operating margin from 15.9% to 20.2%, on revenue of $18.02B in 2025. The 2023 spike in net income ($13.22B) reflects the Climate Technologies divestiture rather than operating earnings, and normalized net income of ~$2.3B in 2025 with FCF of $2.67B shows a steady mature-earner profile. Earnings quality checks are clean: OCF/NI 1.11x, accruals 4% of assets, Beneish -2.63, Altman Z 4.49 in the safe zone.
Verify before trusting this (5)
- What drives the 'weak FCF quality' flag - working capital, capex timing, or one-off items in a specific year?
- Composition and maturity ladder of the $4.80B short-term debt and total debt stack post-AspenTech consolidation
- How much of the 2023 net income of $13.22B was the Climate Technologies gain vs. operating earnings
- Customer/end-market concentration in the reshaped automation portfolio and any pension or contingent liabilities
- AspenTech minority interest treatment and any related dilutive instruments or contingent consideration
The e2e composite fair value lands at $65.45 (signal-adjusted $61.06) versus a $158.71 price, implying about -62% downside if you take the blend at face value. Even the most generous method in the stack - anchored P/E at $135.40 - still sits below the market price, while DCF ($44.19) and EPV floor ($38.03) suggest the current quote requires believing in materially higher through-cycle earnings power than history supports. High earnings quality means no haircut is warranted, and the Strong company-quality grade legitimately lifts deserved value above the DCF/EPV floors - but not by enough to close the gap. A fair deserved value in the $110-135 range (splitting toward the anchored-PE, which credits the margin expansion and buyback discipline) still leaves the stock 15-30% rich. What is priced in: successful continuation of the automation/software mix shift, sustained ~430bps of operating margin gains, and de-leveraging of the $11.6B net-debt stack without disrupting buybacks. That is a lot of good news already embedded, with limited margin of safety if execution wobbles or industrial capex slows.
Verify before trusting this (5)
- Forward organic growth and orders trajectory in automation segments
- Software/ARR disclosure - size, growth, gross margin
- Free cash flow conversion and pace of debt paydown post-Climate Tech divestiture
- Management guidance on through-cycle operating margin ceiling
- Any one-off gains from divestitures inflating current EPS base
The macro tape is modestly constructive - risk-on regime building for six days, VIX at 15.5, indices near highs - and with a beta of 1.24 EMR should get some lift from that. But 10y at 4.65% and a market PE of 26 create a low-grade valuation headwind for exactly the kind of story EMR is being sold on: an industrial re-rated as a software platform. That story is 'strong intensity, moderate durability, low cult' - it is doing work in the multiple but it is not a mania and it is not obviously breaking either. Applied to this name specifically, the automation/digitization narrative is a real tailwind, but the market is not currently paying up for slow, unproven SaaS transitions at legacy conglomerates while Treasuries yield 4.65%. Momentum tells the honest story: 3% recent vs 9% long-term CAGR and -74pp of relative underperformance over three years. That is a tape that has quietly stopped believing the platform pitch, even as the bull thesis remains intact on paper. News flow is thin and non-specific (a generic growth-stocks piece), so there is no fresh catalyst pushing sentiment either way. Net: a mild risk-on lift and an intact-but-tiring narrative roughly offset by rates pressure on the story premium and clearly fading price momentum.
Verify before trusting this (4)
- Whether sector rotation into industrials/automation actually accelerates or stalls in the current risk-on leg
- Any concrete software/ARR disclosure or margin print that either validates or cracks the platform narrative
- Analyst target revisions - if the sell side starts trimming, the story premium unwinds fast
- 10y yield direction; a move back toward 4.3% eases the multiple pressure materially
AI reaches Emerson through three distinct channels that must not be blended: first, demand - AI datacenter, power generation, LNG and semiconductor fab construction directly increases the measurement, final control and discrete automation content Emerson sells, a straightforward volume tailwind unrelated to Emerson's own AI capability; second, cost - a large share of Emerson's delivery is engineering hours for configuration, commissioning and application support, and generative tooling compresses that cost while customers keep paying for the outcome, which is visible in the gross margin move from 41.5 percent to 52.8 percent and operating margin to 20.2 percent even though mix explains much of it; third, and the only genuinely dangerous channel, substitution at the software layer - Emerson bought AspenTech precisely to escape hardware multiples, and AspenTech's value rests on proprietary physics-based process models that data-driven AI can partially approximate from telemetry the customer already owns, so the software transition thesis and the AI risk are the same variable. The physical and liability core is close to untouchable; nobody runs a refinery emergency shutdown on an unvalidated model and no operator wants to own that liability. The question is whether Emerson captures the intelligence layer above its own iron or merely hosts it.
None surfaced.
Verify before trusting this (8)
- Safety certification scope in new products
- Regulator stance on AI in control loops
- Incident-driven specification changes
- ML surrogate model deployments in refining
- Open-source process simulation quality
- AspenTech license pricing trend
- Field service headcount and utilization
- Installed base retention at turnarounds
This lens hasn't been run for this ticker yet.
When we made this prediction on Aug 11, 2026, EMR was $158.71. We expect it to be $141.00 by Feb 2027, and we consider it great value under $120.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 11, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.